Table 3.
Subdivision of COVID-19 Severe patients by outcome in “survivors” and “non-survivors”; CAD: coronary artery diseases; HF: heart failure; PAD: peripheral artery disease; CKD: chronic kidney disease; COPD: Chronic obstructive pulmonary disease.
| Severe “survivors” (20) | Severe “non-survivors” (34) | p-value | |
|---|---|---|---|
| Sex | F: 6 (30%); M: 14 (70%) | F: 10 (29%); M: 24 (71%) | 0.964 |
| Age | 65.00 ± 14.40 | 69.53 ± 9.47 | 0.169 |
| CAD | 5 (25.0%) | 7 (20.6%) | 0.673 |
| HF | 1 (5.0%) | 1 (2.9%) | 0.684 |
| Obesity | 6 (30.0%) | 6 (17.6%) | 0.196 |
| Atrial Fibrillation | 1 (5.0%) | 4 (11.8%) | 0.416 |
| Valvular disease | 1 (5.0%) | 1 (2.9%) | 0.662 |
| PAD | 1 (5.0%) | – | 0.187 |
| Dyslipidemia | 5 (25.0%) | 3 (8.8%) | 0.108 |
| Diabetes mellitus | 4 (20.0%) | 13 (38.2%) | 0.277 |
| Arterial hypertension | 12 (60.0%) | 20 (58.8%) | 1.000 |
| CKD | 3 (15.0%) | 4 (11.8%) | 0.480 |
| Smoking | 6 (30.0%) | 1 (2.9%) | 0.090 |
| COPD | 3 (15.0%) | 6 (17.6%) | 0.776 |
| Autoimmune disease | 1 (5.0%) | 3 (8.8%) | 0.642 |